Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Explore how covalent CDK12 inhibitors are creating breakthroughs in triple-negative breast cancer treatment by targeting DNA repair mechanisms and inducing BRCAness.